학술논문

APhase Ib/II Trial of CombinedBRAFand EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 15 March 2023, 29(6):1017-1030)
Subject
Language
English
ISSN
15573265
10780432